title: Duration of temporary catheter use for hemodialysis: an observational, prospective evaluation of renal units in Brazil.
abstract: BACKGROUND
  For chronic hemodialysis, the ideal permanent vascular access is the arteriovenous fistula (AVF). Temporary catheters should be reserved for acute dialysis needs. The AVF is associated with lower infection rates, better clinical results, and a higher quality of life and survival when compared to temporary catheters. In Brazil, the proportion of patients with temporary catheters for more than 3 months from the beginning of therapy is used as an evaluation of the quality of renal units. The aim of this study is to evaluate factors associated with the time between the beginning of hemodialysis with temporary catheters and the placement of the first arteriovenous fistula in Brazil.
  
  
  METHODS
  This is an observational, prospective non-concurrent study using national administrative registries of all patients financed by the public health system who began renal replacement therapy (RRT) between 2000 and 2004 in Brazil. Incident patients were eligible who had hemodialysis for the first time. Patients were excluded who: had hemodialysis reportedly started after the date of death (inconsistent database); were younger than 18 years old; had HIV; had no record of the first dialysis unit; and were dialyzed in units with less than twenty patients. To evaluate individual and renal unit factors associated with the event of interest, the frailty model was used (N = 55,589).
  
  
  RESULTS
  Among the 23,824 patients (42.9%) who underwent fistula placement in the period of the study, 18.2% maintained the temporary catheter for more than three months until the fistula creation. The analysis identified five statistically significant factors associated with longer time until first fistula: higher age (Hazard-risk - HR 0.99, 95% CI 0.99-1.00); having hypertension and cardiovascular diseases (HR 0.94, 95% CI 0.9-0.98) as the cause of chronic renal disease; residing in capitals cities (HR 0.92, 95% CI 0.9-0.95) and certain regions in Brazil - South (HR 0.83, 95% CI 0.8-0.87), Midwest (HR 0.88, 95% CI 0.83-0.94), Northeast (HR 0.91, 95% CI 0.88-0.94), or North (HR 0.88, 95% CI 0.83-0.94) and the type of renal unit (public or private).
  
  
  CONCLUSIONS
  Monitoring the provision of arteriovenous fistulas in renal units could improve the care given to patients with end stage renal disease.
authors.affiliation: Faculdade de Medicina, Universidade Federal de Minas Gerais, Brazil. gimacedosilva@hotmail.com
authors.forename: Gisele M S
authors.initials: GM
authors.lastname: Bonfante
authors.forename: Isabel C
authors.initials: IC
authors.lastname: Gomes
authors.forename: Eli Iola G
authors.initials: EI
authors.lastname: Andrade
authors.forename: Eleonora M
authors.initials: EM
authors.lastname: Lima
authors.forename: Francisco A
authors.initials: FA
authors.lastname: Acurcio
authors.forename: Mariângela L
authors.initials: ML
authors.lastname: Cherchiglia
mesh_terms: D000328:Adult; D000368:Aged; D000553:Ambulatory Care / Q000592:standards / Q000706:statistics & numerical data; D001166:Arteriovenous Shunt, Surgical / Q000592:standards / Q000706:statistics & numerical data*; D001938:Brazil / Q000453:epidemiology; D002408:Catheters, Indwelling / Q000592:standards / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D016016:Proportional Hazards Models; D011446:Prospective Studies; D011787:Quality of Health Care; D012042:Registries / Q000706:statistics & numerical data; D006435:Renal Dialysis / Q000401:mortality* / Q000592:standards; D013997:Time Factors
references.citation: Rev Saude Publica. 1993 Feb;27(1):49-53
references.pmid: 8310269
references.citation: Kidney Int. 2000 Nov;58(5):2178-85
references.pmid: 11044239
references.citation: Nephrol Dial Transplant. 2007 May;22 Suppl 2:ii88-117
references.pmid: 17507428
references.citation: JAMA. 1996 Oct 23-30;276(16):1303-8
references.pmid: 8861988
references.citation: Kidney Int. 2000 Feb;57(2):639-45
references.pmid: 10652042
references.citation: Cien Saude Colet. 2010 Jan;15(1):171-83
references.pmid: 20169244
references.citation: QJM. 2005 Mar;98(3):183-90
references.pmid: 15728399
references.citation: Nephrol Dial Transplant. 2009 Feb;24(2):578-88
references.pmid: 19028750
references.citation: J Am Soc Nephrol. 2005 May;16(5):1449-55
references.pmid: 15788468
references.citation: Int J Qual Health Care. 2003 Jun;15(3):189-96
references.pmid: 12803346
references.citation: Nefrologia. 2008;28(5):531-8
references.pmid: 18816212
references.citation: Nephrol Dial Transplant. 2008 Oct;23(10):3219-26
references.pmid: 18511606
references.citation: Kaohsiung J Med Sci. 2009 Oct;25(10):521-9
references.pmid: 19767257
references.citation: J Am Soc Nephrol. 2002 Aug;13(8):2117-24
references.pmid: 12138144